This isn't an anti-GLP-1 episode. It's a pro-support one.Zikea McCurdie and Samantha Levin break down the GLP-1 boom and why HR leaders are completely unprepared for it.One in eight American adults has now used a GLP-1. Most got there through a telehealth form with no clinical guardrails and no lifestyle support attached. The drug suppresses appetite. It doesn't build habits. And without employer-side infrastructure, you're looking at muscle loss, nutrient deficiencies, and a yo-yo cycle that shows up in your claims data.In our in-depth conversation, we discuss:

1. Why GLP-1s have reached mainstream scale and what the public conversation is missing
2. The clinical risks nobody is talking about — muscle loss, nutrient deficiencies, no guardrails
3. What these drugs actually do to the body beyond the number on the scale
4. Why lifestyle habits have to be built alongside medication, not after
5. What lasting support actually looks like — movement, nutrition, behavior change
6. Why HR leaders should care and where to start
7. The business case: today's deficiencies become tomorrow's health claims
8. How to actually begin a GLP-1 journey the right way

Road2Wellbeing is a podcast for HR leaders providing real conversations, clinical depth, evidence-based insightsSponsored by Wellness360